PF-Atlas › Clinical Trials › NCT00788138
Effects of Vitamin D Supplementation on Lung Function in an Acute Pulmonary Exacerbation of Cystic Fibrosis
Vitamin D3 · Not specified
Registry ID
NCT00788138
Phase
Not specified
Status
Completed
Drug / intervention
Vitamin D3
Sponsor
Emory University
Start
2008-10
Enrollment
30
Locations
1
About this trial
Vitamin D insufficiency is common in patients with cystic fibrosis. The investigators study will examine a large dose of vitamin D given to patients who have cystic fibrosis and are admitted to the hospital for a pulmonary exacerbation to determine whether vitamin D can improve clinical outcomes and whether the dose given is correct. The investigators hypothesis is that vitamin D therapy will improve production of anti-microbial peptides and will increase bacterial killing of microorganisms.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT00788138 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.